Home

HERB CROSS

CIK 1230721 · Chief Financial Officer · last filed 2026-01-05

HERB CROSS is a Chief Financial Officer who has filed 48 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for JSPRW, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$513.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $123.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$123.8K

Companies

8

Total Filings

48

Lifetime Open-Market Net

-$513.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
JSPRW Chief Financial Officer — $0.01 — $0 5 2026-01-05
Atreca, Inc. (BCEL) Delisted Chief Financial Officer 72,817 $0.15 $10.9K -$18.8K 8 2023-08-04
Apexigen, Inc. (APGNW) Delisted Director — $0.03 — $0 1 2022-10-03
ARMO BioSciences, Inc. (ARMO) Delisted Chief Financial Officer — — — $0 1 2018-06-22
HUMANIGEN, INC (KBIO) Delisted Chief Financial Officer — — — $0 14 2015-11-10
AFFYMAX INC (AFFY) Delisted Chief Financial Officer 21,370 — — -$495.0K 6 2013-02-01
FACT VP of Finance/Prin Acctg Off 11,602 $10.67 $123.8K $0 7 2010-04-21
PDL BIOPHARMA, INC. (PDLI) Delisted Corp Controller/Prin Acctg Off 5,031 — — $0 4 2008-09-17

Recent Filings

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-05 JSPRW Grant (A) — $0 EDGAR
2025-06-06 JSPRW Grant (A) — $0 EDGAR
2025-02-18 JSPRW Grant (A) — $0 EDGAR
2024-02-20 JSPRW Grant (A) — $0 EDGAR
2023-09-26 JSPRW Grant (A) — $0 EDGAR
2023-08-25 — Disp (D) — $0
2023-08-04 Atreca, Inc. (BCEL) Delisted Sell (S) −5,487 -$5.2K EDGAR
2023-02-13 Atreca, Inc. (BCEL) Delisted Grant (A) +43,750 $0 EDGAR
2022-10-03 Apexigen, Inc. (APGNW) Delisted Grant (A) — $0 EDGAR
2022-09-20 Atreca, Inc. (BCEL) Delisted Sell (S) −7,646 -$13.6K EDGAR
Showing 1–10 of 48
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.